Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DTIC (NSC-45388) in malignant melanoma: a perspective.

× No keyword cloud information.

48 in total

1. Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy.

Authors: A I Einzig; L M Schuchter; A Recio; S Coatsworth; R Rodriquez; P H Wiernik
Journal: Med Oncol Date: 1996-06 Impact factor: 3.064

2. Peripheral DTIC neurotoxicity: a case report.

Authors: M Amichetti; S Piffer; R Valdagni; G Ambrosini; M Piazza
Journal: Cancer Chemother Pharmacol Date: 1987 Impact factor: 3.333

3. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

Authors: Murielle Mimeault; Surinder K Batra
Journal: World J Clin Oncol Date: 2012-03-10

4. A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma.

Authors: A L Jones; M E O'Brien; A Lorentzos; C Viner; A Hanrahan; J Moore; J L Millar; M E Gore
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

5. Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases.

Authors: Rajendar K Mittapalli; Shruthi Vaidhyanathan; Arkadiusz Z Dudek; William F Elmquist
Journal: J Pharmacol Exp Ther Date: 2012-12-17 Impact factor: 4.030

6. Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.

Authors: B Jeremic; L Djuric; L Mijatovic
Journal: Invest New Drugs Date: 1991-08 Impact factor: 3.850

7. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.

Authors: William Cruz-Munoz; Shan Man; Robert S Kerbel
Journal: Clin Cancer Res Date: 2009-07-21 Impact factor: 12.531

DTIC (NSC-45388) in malignant melanoma: a perspective.